Superpower Peptides: Blood-Test-Linked Peptide Program Opens for Pre-Order
Why Blood Tests Gate the Prescriptions
Superpower, a telehealth and wellness platform, has launched Superpower Peptides. The new service pairs clinician-prescribed peptide therapies with the company's existing blood testing infrastructure. Pre-orders are open now, with shipments scheduled for late November 2026.
Health news
Exercise and Mood: Italian Study Links Physical Activity to Lower Depression Symptoms
Screen Time in Childhood Linked to Unexpected Cognitive Boost in Teens, 8‑Year Study Shows
Workplace stress and anxiety are taking a heavy toll on employees, with one in three workers reporting that the strain is not easing
Daily Food Habit Tied to Lower Risk of Anxiety and DepressionThe initial catalog features three single-compound peptides: BPC-157, TB-500, and MOTS-C. These are available exclusively to Superpower members who have completed clinical evaluation. The program emphasizes medical oversight, with licensed clinicians reviewing each patient's lab results before prescribing.
Superpower ties peptide access to verified lab data. This design ensures each prescription matches the individual's biomarker profile rather than relying on generic dosing. The company positions the program as a precision-medicine approach, using blood markers to select the right peptide and dosage for each member.
What This Means for Members
The launch follows Superpower's broader push into longevity and performance optimization. Peptide therapy has gained traction among athletes and aging adults seeking recovery and tissue-repair benefits. By integrating testing and treatment under one platform, Superpower aims to reduce friction between diagnosis and prescription.
Members who pre-order now will receive their first shipment at the end of November 2026. The rollout is limited to the three listed compounds at launch, with additional peptides expected later. Superpower says the program will expand based on member demand and clinical feedback.
For users, the key benefit is a closed-loop system: test, prescribe, receive, and monitor. This reduces the need to coordinate between separate labs and clinics. The company also plans to add tracking features so members can view their lab trends over time.
Frequently Asked Questions
Which peptides are available at launch? BPC-157, TB-500, and MOTS-C are the initial offerings. All three are single-compound peptides prescribed after blood-test review.
When will pre-orders ship? Shipping is expected at the end of November 2026. Members who pre-order now will be first in line.
Is a clinician involved in the process? Yes. A licensed clinician reviews each member's blood results and writes the prescription before any peptide is dispensed.